Cargando…

Rifampicin/Cotrimoxazole/Isoniazid Versus Mefloquine or Quinine + Sulfadoxine- Pyrimethamine for Malaria: A Randomized Trial

OBJECTIVES: Previous studies of a fixed combination including cotrimoxazole, rifampicin, and isoniazid (Cotrifazid) showed efficacy against resistant strains of Plasmodium falciparum in animal models and in small-scale human studies. We conducted a multicentric noninferiority trial to assess the saf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Genton, Blaise, Mueller, Ivo, Betuela, Inoni, Casey, Gerard, Ginny, Meza, Alpers, Michael P, Reeder, John C
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2006
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1713262/ https://www.ncbi.nlm.nih.gov/pubmed/17192794 http://dx.doi.org/10.1371/journal.pctr.0010038

Ejemplares similares

The remarkable tenacity of sulfadoxine-pyrimethamine
por: Divala, Titus H, et al.
Publicado: (2019)

Efficacy of sulfadoxine-pyrimethamine in Tanzania after two years as first-line drug for uncomplicated malaria: assessment protocol and implication for treatment policy strategies
por: Mugittu, Kefas, et al.
Publicado: (2005)

Assessment of the Teratogenic Effect of Sulfadoxine-Pyrimethamine on the Chicken Embryo
por: Tari, Rachida Moussa, et al.
Publicado: (2022)

Prevention of malaria in pregnancy: The threat of sulfadoxine-pyrimethamine resistance
por: Sundararaman, Sesh A., et al.
Publicado: (2022)

Marked Reduction in Prevalence of Malaria Parasitemia and Anemia in HIV-Infected Pregnant Women Taking Cotrimoxazole With Or Without Sulfadoxine-Pyrimethamine Intermittent Preventive Therapy during Pregnancy in Malawi
por: Kapito-Tembo, Atupele, et al.
Publicado: (2011)

Risks of Hemolysis in Glucose-6-Phosphate Dehydrogenase Deficient Infants Exposed to Chlorproguanil-Dapsone, Mefloquine and Sulfadoxine-Pyrimethamine as Part of Intermittent Presumptive Treatment of Malaria in Infants
por: Poirot, Eugenie, et al.
Publicado: (2015)

Sulfadoxine/Pyrimethamine Intermittent Preventive Treatment for Malaria during Pregnancy
por: Deloron, Philippe, et al.
Publicado: (2010)

Mortality, Morbidity, and Developmental Outcomes in Infants Born to Women Who Received Either Mefloquine or Sulfadoxine-Pyrimethamine as Intermittent Preventive Treatment of Malaria in Pregnancy: A Cohort Study
por: Rupérez, María, et al.
Publicado: (2016)

Intermittent presumptive treatment in pregnancy with sulfadoxine–pyrimethamine: a counter perspective
por: Nosten, Francois, et al.
Publicado: (2015)

Intermittent Preventive Treatment with Sulfadoxine–Pyrimethamine: More than Just an Antimalarial?
por: Gutman, Julie, et al.
Publicado: (2017)

Molecular monitoring of Plasmodium falciparum super-resistance to sulfadoxine–pyrimethamine in Tanzania
por: Kavishe, Reginald A., et al.
Publicado: (2016)

Molecular Markers for Sulfadoxine/Pyrimethamine and Chloroquine Resistance in Plasmodium falciparum in Thailand
por: Kuesap, Jiraporn, et al.
Publicado: (2022)

Chloroquine and Sulfadoxine–Pyrimethamine Resistance in Sub-Saharan Africa—A Review
por: Roux, Alexandra T., et al.
Publicado: (2021)

Spatiotemporal spread of Plasmodium falciparum mutations for resistance to sulfadoxine-pyrimethamine across Africa, 1990–2020
por: Flegg, Jennifer A., et al.
Publicado: (2022)

Intermittent preventive treatment: efficacy and safety of sulfadoxine-pyrimethamine and sulfadoxine-pyrimethamine plus piperaquine regimens in schoolchildren of the Democratic Republic of Congo: a study protocol for a randomized controlled trial
por: Doua, Joachim Yorokpa, et al.
Publicado: (2013)

Fatal poisoning by isoniazid and rifampicin
por: Sridhar, A., et al.
Publicado: (2012)

Isoniazid- and rifampicin-induced thrombocytopenia
por: Yakar, Fatih, et al.
Publicado: (2013)

Artesunate plus sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum malaria in Sudan
por: Elamin, Sakina B, et al.
Publicado: (2005)

Modelling the impact of antimalarial quality on the transmission of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum
por: Brock, Aleisha R., et al.
Publicado: (2017)

Changing the policy for intermittent preventive treatment with sulfadoxine–pyrimethamine during pregnancy in Malawi
por: Mwendera, Chikondi A., et al.
Publicado: (2017)

Combined chloroquine, sulfadoxine/pyrimethamine and primaquine against Plasmodium falciparum in Central Java, Indonesia
por: Lederman, Edith R, et al.
Publicado: (2006)

Efficacy of pyrimethamine-sulfadoxine in young children with uncomplicated falciparum malaria in rural Burkina Faso
por: Müller, Olaf, et al.
Publicado: (2004)

Randomized Trial of Piperaquine with Sulfadoxine-Pyrimethamine or Dihydroartemisinin for Malaria Intermittent Preventive Treatment in Children
por: Cisse, Badara, et al.
Publicado: (2009)

Effect of Iron/Folic Acid Supplementation on the Outcome of Malaria Episodes Treated with Sulfadoxine-Pyrimethamine
por: Sazawal, Sunil, et al.
Publicado: (2014)

Economic Evaluation of an Alternative Drug to Sulfadoxine-Pyrimethamine as Intermittent Preventive Treatment of Malaria in Pregnancy
por: Sicuri, Elisa, et al.
Publicado: (2015)

Low-grade sulfadoxine–pyrimethamine resistance in Plasmodium falciparum parasites from Lubango, Angola
por: Kaingona-Daniel, Elsa P. S., et al.
Publicado: (2016)

Distribution of Plasmodium vivaxpvdhfr and pvdhps alleles and their association with sulfadoxine–pyrimethamine treatment outcomes in Indonesia
por: Asih, Puji B. S., et al.
Publicado: (2015)

The challenge of using intermittent preventive therapy with sulfadoxine/pyrimethamine among pregnant women in Uganda
por: Wanzira, Humphrey, et al.
Publicado: (2016)

Characterizing the impact of sustained sulfadoxine/pyrimethamine use upon the Plasmodium falciparum population in Malawi
por: Ravenhall, Matt, et al.
Publicado: (2016)

Prevalence of molecular markers of sulfadoxine–pyrimethamine and artemisinin resistance in Plasmodium falciparum from Pakistan
por: Yaqoob, Adnan, et al.
Publicado: (2018)

Pharmacokinetics of Sulfadoxine and Pyrimethamine for Intermittent Preventive Treatment of Malaria During Pregnancy and After Delivery
por: de Kock, M, et al.
Publicado: (2017)

Effect of sulfadoxine-pyrimethamine doses for prevention of malaria during pregnancy in hypoendemic area in Tanzania
por: Mikomangwa, Wigilya P., et al.
Publicado: (2020)

Plasmodium falciparum resistance to sulfadoxine-pyrimethamine in Africa: a systematic analysis of national trends
por: Amimo, Floriano, et al.
Publicado: (2020)

Markers of sulfadoxine–pyrimethamine resistance in Eastern Democratic Republic of Congo; implications for malaria chemoprevention
por: van Lenthe, Marit, et al.
Publicado: (2019)

The usefulness of twenty-four molecular markers in predicting treatment outcome with combination therapy of amodiaquine plus sulphadoxine-pyrimethamine against falciparum malaria in Papua New Guinea
por: Marfurt, Jutta, et al.
Publicado: (2008)

Stable high frequencies of sulfadoxine–pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine–pyrimethamine in Ujjain, Madhya Pradesh, India
por: Pathak, Ashish, et al.
Publicado: (2020)

A Randomized Controlled Trial of Folate Supplementation When Treating Malaria in Pregnancy with Sulfadoxine-Pyrimethamine
por: Ouma, Peter, et al.
Publicado: (2006)

High-level Plasmodium falciparum sulfadoxine-pyrimethamine resistance with the concomitant occurrence of septuple haplotype in Tanzania
por: Baraka, Vito, et al.
Publicado: (2015)

Origins and spread of novel genetic variants of sulfadoxine–pyrimethamine resistance in Plasmodium falciparum isolates in Indonesia
por: Basuki, Sukmawati, et al.
Publicado: (2018)

Erratum: Pharmacokinetics of Sulfadoxine and Pyrimethamine for Intermittent Preventive Treatment of Malaria During Pregnancy and After Delivery
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_avk32e7dpuo18t5pah7njot6s6